FDA approves drug for treatment-resistant depression
March 8, 2019
Media Article Link:
The Guardian, London, featured Walter Dunn, MD, an assistant clinical professor of psychiatry at the Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, in a story about the FDA approval of esketamine for the treatment of depression. Dr. Dunn served on the advisory committee that recommended the drug be approved. The story was syndicated by Yahoo! News.